Authors: Sato M.¹; Harada K.¹; Yoshida H.¹; Yura Y.¹; Azuma M.¹; Iga H.¹; Bando T.¹; Kawamata H.¹; Takegawa Y.²

Source: Apoptosis, Volume 2, Number 2, 1997 , pp. 227-238(12)

Publisher: Springer

Abstract:

Twenty patients with oral squamous cell carcinoma having mainly stage II or III lesions without distant metastasis, were treated with tegafur and streptococcal agent, OK-432, in combination with radiotherapy. As a consequence, 16 cases among the treated 20 cases showed complete remission by this therapy alone. Especially, we have found that the squamous cell carcinoma arising in non-keratinizing oral epithelium rather than in keratinizing oral epithelium has better response to this therapy. Among the 16 cases with complete remission (CR) by the current therapy, 10 cases were histopathologically diagnosed as well-differentiated squamous cell carcinoma and six cases as moderately differentiated squamous cell carcinoma. When we examined immunohistochemically the expres-sion of various antigens such as proliferating cell nuclear antigen (PCNA), p53 and LeY or the presence of DNA fragmentation by nick-end labelling in the biopsy materials taken at the first visit to our clinic from 20 patients treated with the current therapy, the CR group showed a significantly increased LeY expres-sion level ( p< 0.05) and DNA fragmentation rate ( p< 0.05) as compared with the partial response (PR, n= 3) + no change (NC, n= 1) group. On the other hand, the CR group with respect to PCNA expression level was significantly decreased as compared with the PR + NC group ( p< 0.05). From these findings, it can be considered that the therapy for oral squamous cell carcinoma by UFT and OK-432 in combination with radiotherapy is very effective, which may be associated with differentiation or apoptosis in oral squamous carcinoma cells. In addition, we present the clinical findings and results of immunohistochemical staining for the biopsy materials obtained from four CR cases treated with the current therapeutic method.

Keywords: Apoptosis; differentiation; OK-432; oral squamous cell carcinoma; radiotherapy; tegafur

Document Type: Research article

Affiliations: 1: Second Department of Oral and Maxillofacial Surgery, Tokushima University School of Dentistry Tokushima Japan 2: Department of Radiological Technology, Tokushima University School of Medical Sciences Tokushima Japan

Publication date: 1997-01-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Biology ,  Oncology
• By this author: Sato M. ;  Harada K. ;  Yoshida H. ;  Yura Y. ;  Azuma M. ;  Iga H. ;  Bando T. ;  Kawamata H. ;  Takegawa Y.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers